Add like
Add dislike
Add to saved papers

Economic burden of chronic kidney disease in Korea using national sample cohort.

Journal of Nephrology 2017 December
BACKGROUND: Determining the cost of a disease is one of the approaches to estimate the burden of the disease. This study was aimed to estimate the socioeconomic burden of chronic kidney disease (CKD) by CKD stages and treatment strategies in Korea.

METHODS: This was a population-based study designed to estimate the cost of CKD according to CKD stages and treatment strategies from a societal perspective in Korea using multiple data sources. Costs of CKD stages III, IV, and V, hemodialysis (HD), and peritoneal dialysis (PD) were estimated with a prevalence-based method. Costs of kidney transplantation (KT) and post kidney transplantation were estimated using an incidence-based method. Costs consisted of direct medical cost, productivity loss cost due to hospitalization and outpatient visit, caregiver cost, and transportation cost.

RESULTS: Direct medical cost per year per patient with CKD stages III, IV, and V were 1205, 1963, and 8035 Euros, respectively. Direct medical cost per year per patient receiving HD and PD was 34,554 and 25,806 Euros, respectively. Medical cost per year per KT patient was 68,798 Euros. Direct medical cost which accounted for 70% of the total cost of CKD IV and 87% of the total cost of post KT. Cost associated with productivity loss was approximately 8-20%.

CONCLUSIONS: Our findings could be useful for evaluating cost-effectiveness of various CKD interventions including the screening strategy. This study also emphasizes a remarkable increase in the socioeconomic burden associated with the progression of CKD in patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app